Global Medical Cannabis Market Report and Forecast 2023-2031

Global Medical Cannabis Market Report and Forecast 2023-2031


Global Medical Cannabis Market Outlook


The global medical cannabis market value was USD 10.2 billion in 2022, driven by the expanding legalization of medical cannabis across the globe. The market size is anticipated to grow at a CAGR of 24% during the forecast period of 2023-2031 to achieve a value of USD 70.56 billion by 2031.

Medical Cannabis: Introduction

Medical cannabis, derived from the Cannabis sativa plant, has emerged as a promising alternative treatment option for a variety of medical conditions. Despite its long history of traditional use and recent scientific evidence supporting its therapeutic benefits, the plant has faced significant stigma and regulatory hurdles. However, as public opinion and legal frameworks evolve, medical cannabis is gaining acceptance and recognition for its potential to improve patient outcomes in cases where conventional treatments may be inadequate or less effective.

Medical Cannabis Market Scenario

The global medical cannabis market has experienced significant growth in recent years, driven by the increasing awareness of the potential therapeutic benefits of cannabis and its derivatives, as well as a shift in public opinion and regulatory landscape. Medical cannabis has shown promise in treating various medical conditions, including chronic pain, epilepsy, multiple sclerosis, and cancer-related symptoms. As more countries move towards legalizing medical cannabis and research continues to unlock new therapeutic applications, the market is expected to witness substantial growth in the coming years. Factors driving the growth of the medical cannabis market include:
  • Expanding legalization of medical cannabis across various countries and states.
  • Rising awareness of the potential therapeutic benefits of cannabis for various medical conditions.
  • Increasing investments in research and development by both public and private entities.
The regulatory environment for medical cannabis varies significantly across countries and regions. Some countries, such as Canada and certain U.S. states, have broadly legalized medical cannabis, while others have a more restrictive approach or only allow specific cannabis-derived pharmaceuticals.

The medical cannabis market is influenced by regional factors, including legal status, demand patterns, and the presence of key market players. North America is currently the largest market, followed by Europe. However, Asia-Pacific and Latin America are expected to experience significant growth as their legal frameworks evolve and awareness of medical cannabis increases.

The medical cannabis market is expected to continue its growth trajectory, driven by factors such as technological advancements, novel therapeutic applications, and emerging markets. The market's potential may also be shaped by changes in the regulatory landscape and increasing adoption by the medical community.

Medical Cannabis Market Segmentations

Market Breakup by Product Type
  • Dried Medical Cannabis
  • Medical Cannabis Capsules
  • Vape Pen
  • Whole Flower
  • Creams and Moisturizer
  • Ground Flower
  • Patch
  • Oil
  • Mask and Serum
  • Cleanser
  • Others
Market Breakup by Species
  • Sativa
  • Hybrid
  • Cannabis Indica
Market Breakup by Derivatives
  • Market Overview
  • Cannabidiol (CBD)
  • Tetrahydrocannabinol (THC)/Delta-8-Tetrahydrocannabinol
  • Cannabigerol (CBG)
  • Cannabinol
  • Others
Market Breakup by Sources
  • Natural
  • Synthetic
Market Breakup by Applications
  • Pain Management
  • Anxiety
  • Muscle Spasms
  • Nausea
  • Appetite Loss
  • Cancer
  • Arthritis
  • Alzheimer's Disease
  • Epilepsy
  • Depression and Sleep Disorders
  • Multiple Sclerosis
  • Autism
  • Mental Health Conditions
  • Elevate Mood
  • Others
Market Breakup by Route of Administration
  • Oral Solutions and Capsules
  • Smoking
  • Topicals
  • Vaporizers
  • Others
Market Breakup by End User
  • Homecare Settings
  • Hospital
  • Rehab Centers
  • Pharmaceutical Industry
  • Research and Development Centers
  • Others
Market Breakup by Distribution Channels
  • B2B
  • B2C
Market Breakup by Region
  • North America
  • United States of America
  • Canada
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Key Trends in the Medical Cannabis Market


The key trends observed in the medical cannabis market include:
  • Clinical Trials and Research: The number of clinical trials and research studies investigating the safety, efficacy, and potential applications of medical cannabis has been increasing, contributing to a growing body of scientific evidence supporting its therapeutic use.
  • Cannabis-derived Pharmaceuticals: The development and approval of cannabis-derived pharmaceuticals, such as Epidiolex (for certain forms of epilepsy) and Sativex (for multiple sclerosis-related spasticity), have demonstrated the medical potential of cannabis and its active compounds.
  • Product Innovation and Diversification: Companies in the medical cannabis market are focusing on innovation and diversification, developing new strains, formulations, and delivery methods to cater to different patient needs and preferences.
  • Personalized Medicine: The growing interest in personalized medicine has led to a focus on tailoring medical cannabis treatments to individual patient profiles, considering factors such as genetic makeup, the severity of the condition, and response to other treatments.
  • Expanding Legalization: The trend of legalizing medical cannabis in various countries and states has been gaining momentum, resulting in increased access to patients and growth in the market.
  • Telemedicine and Online Platforms: With the rise of telemedicine and digital platforms, patients can now more easily obtain medical cannabis recommendations and prescriptions from healthcare providers, as well as purchase products from online dispensaries.
  • Consumer Education and Awareness: Companies, patient advocacy groups, and medical professionals are making efforts to educate consumers about the potential therapeutic benefits of medical cannabis, dispelling misconceptions and reducing stigma associated with its use.
  • Sustainability and Social Responsibility: The medical cannabis industry is increasingly focusing on sustainable cultivation practices, environmental conservation, and social responsibility initiatives to address concerns about the environmental and social impacts of cannabis production.
Medical Cannabis Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the medical cannabis market are as follows:
  • Joy Organics
  • CBD istillery
  • Gaia Botanicals
  • Harmony
  • Floyd’s of Leadville
  • Lazarus Naturals
  • Pure Hemp Botanicals
  • ENDOCA
  • Green Roads
  • Tilray
  • Canopy Growth Corp.
  • GW Pharmaceuticals PLC
  • Aurora Cannabis
  • Aphria Inc.
  • CV sciences Inc.
*Please Note:* The report will be completed in 7 business days after order confirmation


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Medical Cannabis Market Overview
3.1 Global Medical Cannabis Market Historical Value (2016-2022)
3.2 Global Medical Cannabis Market Forecast Value (2023-2031)
4 Global Medical Cannabis Market Landscape
4.1 Global Medical Cannabis Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Medical Cannabis Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Applications
4.2.3 Analysis by End User
5 Global Medical Cannabis Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Medical Cannabis Market Segmentation
6.1 Global Medical Cannabis Market by Product Type
6.1.1 Market Overview
6.1.2 Dried Medical Cannabis
6.1.3 Medical Cannabis Capsules
6.1.4 Vape Pen
6.1.5 Whole Flower
6.1.6 Creams and Moisturizer
6.1.7 Ground Flower
6.1.8 Patch
6.1.9 Oil
6.1.10 Mask and Serum
6.1.11 Cleanser
6.1.12 Others
6.2 Global Medical Cannabis Market by Species
6.2.1 Market Overview
6.2.2 Sativa
6.2.3 Hybrid
6.2.4 Cannabis Indica
6.3 Global Medical Cannabis Market by Derivatives
6.3.1 Market Overview
6.3.2 Cannabidiol (CBD)
6.3.3 Tetrahydrocannabinol (THC)/Delta-8-Tetrahydrocannabinol
6.3.4 Cannabigerol (CBG)
6.3.5 Cannabinol
6.3.6 Others
6.4 Global Medical Cannabis Market by Sources
6.4.1 Market Overview
6.4.2 Natural
6.4.3 Synthetic
6.5 Global Medical Cannabis Market by Applications
6.5.1 Market Overview
6.5.2 Pain Management
6.5.3 Anxiety
6.5.4 Muscle Spasms
6.5.5 Nausea
6.5.6 Appetite Loss
6.5.7 Cancer
6.5.8 Arthritis
6.5.9 Alzheimer's Disease
6.5.10 Epilepsy
6.5.11 Depression and Sleep Disorders
6.5.12 Multiple Sclerosis
6.5.13 Autism
6.5.14 Mental Health Conditions
6.5.15 Elevate Mood
6.5.16 Others
6.6 Global Medical Cannabis Market by Route of Administration
6.6.1 Market Overview
6.6.2 Oral Solutions and Capsules
6.6.3 Smoking
6.6.4 Topicals
6.6.5 Vaporizers
6.6.6 Others
6.7 Global Medical Cannabis Market by End User
6.7.1 Market Overview
6.7.2 Homecare Settings
6.7.3 Hospital
6.7.4 Rehab Centers
6.7.5 Pharmaceutical Industry
6.7.6 Research and Development Centers
6.7.7 Others
6.8 Global Medical Cannabis Market by Distribution Channels
6.8.1 Market Overview
6.8.2 B2B
6.8.3 B2C
6.9 Global Medical Cannabis Market by Region
6.9.1 Market Overview
6.9.2 North America
6.9.3 Europe
6.9.4 Asia Pacific
6.9.5 Latin America
6.9.6 Middle East and Africa
7 North America Medical Cannabis Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Medical Cannabis Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Medical Cannabis Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Medical Cannabis Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Medical Cannabis Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Joy Organics
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 CBD istillery
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Gaia Botanicals
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Harmony
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Floyd’s of Leadville
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Lazarus Naturals
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Pure Hemp Botanicals
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 ENDOCA
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Green Roads
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Tilray
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Canopy Growth Corp.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 GW Pharmaceuticals PLC
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Aurora Cannabis
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Aphria Inc.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 CV sciences Inc.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Medical Cannabis Market- Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings